The protein encoded by this gene is a member of the apolipoprotein C1 family. This gene is expressed primarily in the liver, and it is activated when monocytes differentiate into macrophages. A pseudogene of this gene is located 4 kb downstream in the same orientation, on the same chromosome. This gene is mapped to chromosome 19, where it resides within a apolipoprotein gene cluster. Alternatively spliced transcript variants have been found for this gene, but the biological validity of some variants has not been determined. [provided by RefSeq, Jul 2008].
Fukuhara, Wada, Nakamura, Ono, Shiokawa, Yamamoto, Motomura, Okamoto, Okuzaki, Yamamoto, Saito, Wakita, Koike, Matsuura: "Amphipathic ?-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particles." in: PLoS pathogens, Vol. 10, Issue 12, pp. e1004534, (2014) (PubMed).
Sun, Lin, Lee, Wang, Cheng, Wu, Chang, Lai, Shieh, Young: "Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III." in: Gut, Vol. 62, Issue 8, pp. 1193-203, (2013) (PubMed).
Andersson, Hellgren, Nierop, Hochberg, Albertsson-Wikland: "Proteins related to lipoprotein profile were identified using a pharmaco-proteomic approach as markers for growth response to growth hormone (GH) treatment in short prepubertal children." in: Proteome science, Vol. 7, pp. 40, (2009) (PubMed).
Meunier, Russell, Engle, Faulk, Purcell, Emerson: "Apolipoprotein c1 association with hepatitis C virus." in: Journal of virology, Vol. 82, Issue 19, pp. 9647-56, (2008) (PubMed).
Berbée, van der Hoogt, Sundararaman, Havekes, Rensen: "Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL." in: Journal of lipid research, Vol. 46, Issue 2, pp. 297-306, (2005) (PubMed).